WATSON 3359 WATSON 3359 (Tacrolimus 5 mg)

Pill imprint WATSON 3359 WATSON 3359 has been identified as Tacrolimus 5 mg.

Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal; graft-versus-host disease; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WATSON 3359 WATSON 3359 (Tacrolimus 5 mg)

Tacrolimus 5 mg WATSON 3359 WATSON 3359
Tacrolimus
Imprint:
WATSON 3359
WATSON 3359
Strength:
5 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcineurin inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-3359
Inactive Ingredients:
lactose anhydrous
croscarmellose sodium
hypromelloses
magnesium stearate
gelatin
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
FD&C Red No. 40

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)